Search of a new tumor marker and examination of usefulness by multi-institutinal study
Not Applicable
Recruiting
- Conditions
- Breast cancer, Thyroid cancer, Esophageal cancer, Gastric cancer, Colon cancer, Liver cancer, Biliary cancer, Pancreatic cancer
- Registration Number
- JPRN-UMIN000014530
- Lead Sponsor
- Toho Univerisity
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Patients who are judged inappropriate for this study by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumor markers to be analyzed are as follows. Positive rate of each tumor marker. Analysis of correlation with clinicopathological factors and various blood concentration. -New tumor markers(cancer-specific protein and IgG antibody cancer antigen-specific antibody such as SEREX) -Existing tumor markers(p53 antibody, CEA, SCC-Ag, CYFRA21-1, AFP, CA19-9, CA125, midkine, TPA, and IAP)
- Secondary Outcome Measures
Name Time Method